Repligen financials
$194.57+0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $204.1M | $194.3M | $197.9M | $188.8M | $182.4M | $169.2M | $167.5M | $154.9M | $158.8M | $153.2M | $166.6M | $141.2M |
| Gross profit | $110.0M | $108.3M | $103.8M | $100.5M | $93.0M | $91.4M | $38.8M | $77.5M | $81.5M | $76.8M | $78.5M | $36.6M |
| Gross margin | 53.9% | 55.7% | 52.5% | 53.2% | 51.0% | 54.0% | 23.2% | 50.0% | 51.3% | 50.1% | 47.1% | 25.9% |
| Operating income | $14.0M | $15.9M | $17.9M | $16.8M | $13.9M | $6.6M | -$36.5M | -$7.8M | $5.5M | $3.8M | $9.9M | $4.7M |
| Net income | $5.0M | $8.3M | $13.3M | $14.9M | $14.9M | $5.8M | -$33.9M | -$654.0K | $5.7M | $3.3M | -$16.4M | $16.9M |
| Net margin | 2.5% | 4.3% | 6.7% | 7.9% | 8.2% | 3.4% | −20.2% | −0.4% | 3.6% | 2.2% | −9.9% | 12.0% |
| Diluted EPS | $0.09 | $0.15 | $0.23 | $0.26 | $0.26 | $0.10 | $-0.62 | $-0.01 | $0.10 | $0.06 | $-0.30 | $0.30 |
| EBITDA | $38.1M | $37.1M | $38.3M | $37.9M | $28.2M | $27.3M | -$18.1M | $9.6M | $22.4M | $20.7M | $10.6M | -$9.8M |
| Operating cash flow | $32.8M | $28.3M | $25.7M | $48.1M | $28.6M | $15.0M | $39.2M | $49.3M | $42.2M | $44.7M | -$2.2M | $39.2M |
| Free cash flow | $27.4M | $23.6M | $17.6M | $43.4M | $21.5M | $11.4M | $33.6M | $42.3M | $37.4M | $36.4M | -$13.3M | $30.8M |
| Diluted shares | 56.6M | 56.7M | 56.6M | 56.5M | 56.5M | 56.6M | 54.8M | 56.0M | 56.4M | 56.5M | 54.7M | 56.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $606.8M | $582.6M | $566.0M | $748.7M | $708.9M | $697.2M |
| Short-term investments | $203.7M | $201.9M | $201.6M | $0.00 | $0.00 | $0.00 |
| Total debt | $551.0M | $546.6M | $542.2M | $537.9M | $533.7M | $529.6M |
| Total assets | $2.95B | $2.93B | $2.95B | $2.92B | $2.90B | $2.85B |
| Total liabilities | $838.1M | $825.3M | $843.6M | $840.6M | $839.9M | $866.7M |
| Shareholders' equity | $2.11B | $2.11B | $2.11B | $2.08B | $2.06B | $1.99B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology